Pulmonary Gas Exchange during Sleep in Patients with Airflow Limitation Undergoing Long-Term Oxygen Therapy

Dunne PJ . The demographics and economics of long-term oxygen therapy. Respir Care 2000;45(2):223–228; discussion 228–230.

O'Donohue WJ Jr , editor. Long-term oxygen therapy: scientific ba-sis and clinical application. New York: Marcel Dekker; 1995.

Kacmarek RM . Delivery systems for long-term oxygen therapy. Respir Care 2000;45(1):84–92; discussion 92–94.

McNicholas WT . Impact of sleep in COPD. Chest 2000;117(2 Suppl):48S–53S.

Robin ED . Some interactions between sleep and disease. Arch Intern Med 1958;102:669–675.

Koo KW , Sax DS , Snider GL . Arterial blood gases and pH during sleep in chronic obstructive pulmonary disease. Am J Med 1975;58(5):663–670.

Flick MR , Block AJ . Continuous in vivo monitoring of arterial ox-ygenation in chronic obstructive lung disease. Ann Intern Med 1977;86(6):725–730.

Douglas NJ , Calverley PMA , Leggett RJE , Brash HM , Flenley DC , Brezinova V. Transient hypoxaemia during sleep in chronic bron-chitis and emphysema. Lancet 1979;1(8106):1–4.

Flenley DC . Clinical hypoxia: causes, consequences, and correction. Lancet 1978;1(8063):542–546.

Block AJ , Boysen PG , Wynne JW . The origins of cor pulmonale: a hypothesis. Chest 1979;75(2):109–110.

Śliwiński P , Łagosz M , Górecka D , Zieliński J. The adequacy of oxy-genation in COPD patients undergoing long-term oxygen therapy as-sessed by pulse oximetry at home. Eur Respir J 1994;7(2):274–278.

Pływaczewski R , Śliwiński P , Nowiński A , Kamiński D , Zieliński J. Incidence of nocturnal desaturation while breathing oxygen in COPD patients undergoing long-term oxygen therapy. Chest 2000;117(3):679–683.

Tárrega J , Güell R , Anton A , Mayos M , Farre A , Jerez FR , Sanchis J. Are daytime arterial blood gases a good reflection of nighttime gas exchange in patients on long-term oxygen therapy? Respir Care 2002;47(8):882–886.

Rist KE , Doubenspeck JA , McGovern JF . Effects of non-REM sleep upon respiratory drive and the respiratory pump in humans. Respir Physiol 1986;63(2):241–256.

Radwan L , Dufmats H. Variations of arterial oxygen and carbon dioxide tension during 24 hours in chronic respiratory insufficiency. Scand J Respir Dis 1974;55(2):99–104.

Coccagna G , Mantovani M , Brignani F , Parchi C , Lugaresi E. Con-tinuous recording of the pulmonary and systemic arterial pressure during sleep in syndromes of hypersomnia with periodic breathing. Bull Physiopathol Respir (Nancy) 1972;8(5):1159–1172.

American Thoracic Society statement. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1995;152(5 Pt 2):S77–S121.

Nocturnal Oxygen Therapy Trial Group. Continuous or nocturnal oxygen therapy in hypoxemic chronic obstructive lung disease: a clinical trial. Ann Intern Med 1980;93(3):391–398.

Śliwiński P , Bieleń P , Nowiński A , Zieliński J. The effects of dif-ferent oxygen flow rates on CO₂ retention in COPD patients quali-fied for LTOT (abstract). Eur Respir J 1999;14 Suppl 30:119s.

Fletcher EC , Miller J , Divine GW , Fletcher JG , Miller T. Nocturnal oxyhemoglobin desaturation in COPD patients with arterial oxygen tension above 60 mm Hg. Chest 1987;92(4):604–608.

Levi-Valensi P , Aubry P , Rida Z. Nocturnal hypoxemia and long-term therapy in COPD patients with daytime Paco₂ 60-70 mmHg. Lung 1990;168 Suppl:770–775.

Zieliński J. Indications for long-term oxygen therapy: a reappraisal. Monaldi Arch Chest Dis 1999;54(2):178–182.

O'Donohue WJ Jr , Bowman TJ . Hypoxemia during sleep in patients with chronic obstructive pulmonary disease: significance, detection, and effects of therapy. Respir Care 2000;45(2):188–191; discussion 192–193.

Fletcher EC , Levin DC . Cardiopulmonary hemodynamics during sleep in subjects with chronic obstructive pulmonary disease: the effect of short- and long-term oxygen. Chest 1984;85(1):6–14.

Fletcher EC , Luckett RA , Miller T , Fletcher JG . Exercise hemody-namics and gas exchange in patients with chronic obstruction pul-monary disease, sleep desaturation, and a daytime Paco₂ above 60 mm Hg. Am Rev Respir Dis 1989;140(5):1237–1245.

Fletcher EC , Luckett RA , Goodnight-White S , Miller CC , Qian W , Costarangos-Galarza C. A double-blind trial of nocturnal supple-mental oxygen for sleep desaturation in patients with chronic ob-structive pulmonary disease and a daytime Paco₂ above 60 mm Hg. Am Rev Respir Dis 1992;145(5):1070–1076.

Fletcher EC , Donner CF , Midgren B , Zieliński J , Levi-Valensi P , Braghiroli A , et al. Survival in COPD patients with a daytime Paco₂ greater than 60 mm Hg with and without nocturnal oxyhemoglobin desaturation. Chest 1992;101(3):649–655.

Fletcher EC , Scott D , Qian W , Luckett RA , Miller CC , Goodnight-White S. Evolution of nocturnal oxyhemoglobin desaturation in pa-tients with chronic obstructive pulmonary disease and a daytime Paco₂ above 60 mm Hg. Am Rev Respir Dis 1991;144(2):401–405.

Chaouat A , Weitzenblum E , Kessler R , Charpentier C , Ehrhart M , Levi Valensi P , et al. Sleep-related O₂ desaturation and daytime pulmonary haemodynamics in COPD patients with mild hypoxae-mia. Eur Respir J 1997;10(8):1730–1735.

Chaouat A , Weitzenblum E , Kessler R , Charpentier C , Ehrhart M , Schott R , et al. A randomised trial of nocturnal oxygen therapy in chronic obstructive pulmonary disease patients. Eur Respir J 1999;14(5):1002–1008.

Chaouat A , Weitzenblum E , Kessler R , Schott R , Charpentier C , Levi-Valensi P , et al. Outcome of COPD patients with mild daytime hypoxaemia with or without sleep-related oxygen desaturation. Eur Respir J 2001;17(5):848–855.

O'Donohue WJ Jr . Current concepts in supplemental oxygen therapy in patients with COPD. Semin Respir Crit Care Med 1999;20:341–350.